ICON plc | Clinical Research Organisation (CRO) for Drug Development

Patient centricity in orphan drug development

Patient involvement in the development of drugs for rare diseases.

COVID-19: Navigating global market access requirements

Recommendations to maxmise HTA success.

Decentralised and hybrid clinical trials

Considerations in planning and executing.

Advancing digital endpoints

Navigating the shift from traditional trial models to agile, patient-centric processes.

Webinars

Quality cell and gene therapies outcomes through multidisciplinary collaboration

24 September, 10AM EST. Register now.

Reducing site burden and increasing trial efficiency

1 October 2020, 11AM EST. Register now.

Real world data mapping

5 October, 9AM EST. Register now.

On-demand webinar archive

Visit our webinar channel to access our entire library of archived webinars.

Featured Services

COVID-19 clinical operations

Keeping your clinical trial on track in an evolving environment.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Biosimilars

ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

14 September 2020

Reducing disruptions of cardiovascular trials and ensuring trial integrity during a global pandemic

The COVID-19 pandemic has not only impacted access to healthcare, but also significantly disrupted the conduct of clinical trials investigating therapies intended to treat cardiovascular (CV) diseases.

01 September 2020

Remote management: The new normal in a post-COVID world

As procedures typically carried out on-site continue to be managed remotely, sponsors will need to implement a remote clinical trial management strategy to mitigate further roadblocks that may arise and keep clinical trials moving forward.

20 August 2020

ISO 14155: Increased emphasis on clinical data continues to trend for medical device regulations

Over the past several years, regulations for the medical device industry have continued to evolve placing more emphasis on clinical data and patient safety.

17 August 2020

Best practices for designing digital endpoints for COVID-19 clinical trials amid uncertainty

Utilising data from sensors, wearables and other digital health technologies can provide critical information on COVID- 19 related symptoms and identify digital biomarkers in real- time.

13 August 2020

Effective patient recruitment for rare disease research

With 350 million people affected worldwide, rare diseases represent a major unmet medical need. However, the timely recruitment of eligible participants is a challenge for any rare disease clinical trial.

05 August 2020

Post pandemic clinical trial strategies: How COVID-19 altered clinical trials forever and what’s next

The COVID-19 pandemic forced the clinical trials industry to accept and accelerate the use of digital health technologies.

20 July 2020

Encouraging patient participation in real world studies

Real world data offers an alternative approach to observational research, particularly to inform decisions on patient needs and preferences.

01 July 2020

Juvenile Arthritis Awareness Month: This fight is personal

This blog is a condensed version of an ICON employee’s’ personal journey of courage and endurance.

24 June 2020

Enabling clinical development of cell and gene therapies on a global basis

In a recent podcast interview, ICON experts discuss the intricacies of CGT development, the solutions that will enable CGT development on a global basis, and the future of CGT clinical trials.

Coronavirus Observatory

Aggregated news, stats and social media on covid-19 clinical trials. Visit Observatory

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Agile Clinical Monitoring

ICON launches Accellacare

Mitigating the impact of COVID-19 on cardiovascular trials

Patient Centricity